TGF-β1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion

Journal of Cell Science

Volumn 114, Issue 21, 2001, Pages 3905-3914

  Kutz, S M ^a   Hordines, J ^a   McKeown Longo, P J ^a   Higgins, P J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Gene expression; PAI 1; Signal transduction; TGF 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AGAROSE; FIBRONECTIN; GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN TYROSINE KINASE; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; VITRONECTIN; ENZYME INHIBITOR; EXTRACELLULAR SIGNAL-REGULATED KINASE 1; FLAVONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASES; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE SWITCHING; GENE TARGETING; GENETIC TRANSCRIPTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; RNA SYNTHESIS; SIGNAL TRANSDUCTION; SUSPENSION; CELL LINE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

CELL ADHESION; CELL LINE; ENZYME INHIBITORS; FIBRONECTINS; FLAVONES; GENE EXPRESSION; HUMAN; MITOGEN-ACTIVATED PROTEIN KINASES; P42 MAP KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN;

EID: 0034747099     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Targets of transcriptional regulation by transforming growth factor-β: Expression profile analysis using oligonucleotide arrays
2. The urokinase-type plasminogen activator system in cancer metastasis: A review
3. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies
4. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-β1
5. TGF β1 promotes actin cytoskeleton reorganization and migratory phenotype in epithelial tracheal cells in primary culture
6. Mouse L cells expressing human prourokinase-type plasminogen activator: Effects on extracellular matrix degradation and invasion
7. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells
8. Plasminogen activators, integrins, the coordinate regulation of cell adhesion and migration
9. Plasminogen activator inhibitor type 1 stabilizes vitronectin-dependent adhesions in HT-1080 cells
10. Endothelial cell integrin α5β1 expression is modulated by cytokines and during migration in vitro
11. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction
12. Transforming growth factor-β overrides the adhesion requirement for surface expression of α5β1 integrin in normal rat kidney fibroblasts. A necessary effect for induction of anchorage-independent growth
13. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
14. ERK and p38 MAP kinase pathways are mediators of intestinal epithelial wound-induced signal transduction
15. Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: Involvement of mitogen-activated protein kinase cascades
16. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism
17. Basic fibroblast growth factor and transforming growth factor β-1: Synergistic mediators of angiogenesis in vitro
18. Fate of human keratinocytes during reepithelialization in an organotypic culture model
19. Kinetic analysis of integrin-dependent cell adhesion on vitronectin - The inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides
20. Urinary-type plasminogen activator (uPA) and uPA receptor localization are regulated by α3β1 integrin in oral keratinocytes
21. Trefoil peptides promote restitution of wounded corneal epithelial cells
22. Signaling of deadhesion in cellular regulation and motility
23. Transforming growth factor β activation of p44MAPK in proliferating cultures of epithelial cells
24. Cell-shape regulation and matrix protein p52 content in phenotypic variants of ras-transformed rat kidney fibroblasts
25. Cell shape-associated transcriptional activation of the p52(PAI-1) gene in rat kidney cells
26. PAI-1 gene expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells: Mechanism of induction and involvement in the morphologic response
27. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway
28. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor αvβ3
29. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
30. Regulation of cell motility by mitogen-activated protein kinase
31. Induced PAI-1 mRNA expression and targeted protein accumulation are early G1 events in serum-stimulated rat kidney cell
32. Antisense targeting of c-fos transcripts inhibits serum- and TGF-β1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells
33. Transforming growth factor-β up-regulates the β5 integrin subunit expression via Sp1 and Smad signaling
34. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis
35. uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial cell migration
36. Cell anchorage permits efficient signal transduction between ras and its downstream kinases
37. Regulation of cell adhesion by PAI-1
38. Functional overlap between two classes of matrix-degrading proteases in wound healing
39. Wound healing - Aiming for perfect skin regeneration
40. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
41. Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology
42. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis
43. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair
44. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility
45. Urokinase-type plasminogen activator mediates basic growth factor-induced bovine endothelial migration independent of its proteolytic activity
46. Differential gene expression in migrating renal epithelial cells after wounding
47. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells
48. Plasminogen activator inhibitor-1 is induced in migrating capillary endothelial cells
49. Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism
50. PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair
51. Migration of arterial wall cells
52. Growth factor activation of MAP kinase requires cell adhesion
53. Mesosecrin: A secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture
54. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway
55. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds
56. The receptor for urokinase-type plasmingoen activator is expressed by keratinocytes at the leading edge during re-epitheliazation of mouse skin wounds
57. Impaired wound healing in mice with a disrupted plasminogen gene
58. α5β1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells
59. Growth state-regulated expression of p52(PAI-1) in normal rat kidney cells
60. Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion
61. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen ativator synthesis, and DNA synthesis
62. The EGF-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the migration tracks
63. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin
64. Transforming growth factor-β1 expression in cultured corneal fibroblasts in response to injury
65. The serpin PAI-1 inhibits cell migration by blocking αvβ5 binding to vitronectin
66. Regulation of the expression of a secreted acidic protein rich is cysteine (SPARC) in human fibroblasts by transforming growth factor β. Comparison of transcriptional and post-transcriptional control with and type I collagen
67. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing
68. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesion independently of the motility-associated PLCγ signaling pathway
69. Provisional matrix
70. Integrins in wound repair
71. Transforming growth factor-β stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation
72. Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium
73. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the αvβ6 heterodimer in normal human keratinocytes: Implications for wound healing
74. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β
75. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis
76. Integrin-dependent activation of MAP kinase: A link to shape-dependent cell proliferation
77. TGFβ1 induces a cell-cycle-dependent increase in motility of epithelial cells